L03AA13 • pegfilgrastim • Antineoplastic and immunomodulating agents | Immunostimulants | Colony stimulating factors
Pegfilgrastim is a medication used to reduce the risk of infections in patients undergoing chemotherapy that causes neutropenia (a decrease in neutrophil count). It is a pegylated granulocyte colony-stimulating factor (G-CSF) that stimulates the production of neutrophils in the bone marrow.
The medication is administered as a subcutaneous injection, usually once per chemotherapy cycle, as directed by your doctor. It is important to monitor neutrophil counts and report any adverse reactions.
Side effects may include bone pain, fatigue, nausea, or injection site reactions. In rare cases, severe reactions such as acute respiratory distress syndrome or splenic rupture may occur.
Patients should inform their doctor about any other medications being used or pre-existing conditions to ensure the safe use of pegfilgrastim.
Substance: pegfilgrastim
Date of last drug list: 01-07-2013
Commercial code: W51598001
Concentration: 6mg
Pharmaceutical form: injectible solution
Quantity: 1
Product type: original
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).